(Q30412726)

17 August 2017

Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction (English)

1 reference

17 August 2017

0 references

1 reference

ventricular dysfunction

1 reference

idiopathic pulmonary fibrosis

inferred from title

1 reference

7

Kevin J Anstrom

1 reference

17 August 2017

8

Fernando J Martinez

1 reference

17 August 2017

MeiLan K Han

1

1 reference

17 August 2017

David S Bach

2

1 reference

17 August 2017

Peter G Hagan

3

1 reference

17 August 2017

Eric Yow

4

1 reference

17 August 2017

Kevin R Flaherty

5

1 reference

17 August 2017

Galen B Toews

6

1 reference

17 August 2017

IPFnet Investigators

9

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 June 2013

1 reference

17 August 2017

1 reference

17 August 2017

143

1 reference

17 August 2017

6

1 reference

17 August 2017

1699-1708

1 reference

Plasma endothelin-1 and vascular endothelial growth factor levels and their relationship to hemodynamics in idiopathic pulmonary fibrosis.

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3673665

BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3673665

A controlled trial of sildenafil in advanced idiopathic pulmonary fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3673665

The SF-36 and SGRQ: validity and first look at minimum important differences in IPF.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3673665

Updated evidence-based treatment algorithm in pulmonary arterial hypertension.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3673665

Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3673665

Pulmonary diseases and the heart

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3673665

Pulmonary hypertension in idiopathic pulmonary fibrosis.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3673665

Sildenafil improves walk distance in idiopathic pulmonary fibrosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3673665

Sildenafil citrate therapy for pulmonary arterial hypertension

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3673665

Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3673665

Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3673665

BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3673665

Effects of Aerosol vs IV UT-15 on Prostaglandin H2 Analog-Induced Pulmonary Hypertension in Sheep

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3673665

Pulmonary Hypertension in Patients With Idiopathic Pulmonary Fibrosis

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3673665

Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3673665

Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3673665

Pulmonary hemodynamics in idiopathic pulmonary fibrosis and other interstitial pulmonary diseases.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3673665

Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23732584

12 December 2020

inferred from PubMed ID database lookup

Pulmonary hypertension in interstitial lung disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23732584

12 December 2020

inferred from PubMed ID database lookup

Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23732584

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1378/CHEST.12-1594

1 reference

release_463pqgimive3zhcbrtmtpny7zu

17 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/463pqgimive3zhcbrtmtpny7zu

24 November 2022

mapped directly with Wikidata item

1 reference

17 August 2017

PubMed publication ID

23732584

1 reference